Combating the Ever-Increasing Issue of Antimicrobial Resistance with a One Health Strategy in Environment and Medical Systems
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 8240
Special Issue Editors
Interests: microbiome; antimicrobial resistance; metagenomic next generation sequencing (mNGS); bioinformatics
Special Issues, Collections and Topics in MDPI journals
Interests: metagenomics; antimicrobial resistance; microbial ecology; drinking water; biotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The emerging antimicrobial resistance (AMR) poses a great threat to public health. The top ten global health threats proposed by the World Health Organization (WHO) in 2019 include the ever-increasing AMR issue. Due to the wide application of antibiotics in recent decades, antimicrobial resistance genes (ARGs) have been transmitted, disseminated, and cycled among various environments and human medical systems, resulting in a one-health issue. A one-health combating strategy is urgently needed. The AMR of clinical important pathogenic species and environment dissemination have been extensively investigated; however, a holistic view of the distribution and dissemination of ARGs in all microorganisms is still lacking. Thanks to the development and maturation of clinical and environmental metagenomic next/third-generation sequencing, in combination with culturing and imaging, the community is heading towards a better understanding of the issue and the development of mitigation strategies.
This Special Issue will include topics related to 1) ARG dissemination in public health related system; 2) ARGs in emerging pathogens for various diseases; 3) Mobility of antimicrobial resistance genes in mobile genetic elements; 4) Novel treatment of drug-resistance bacteria by phage therapy or other antimicrobial strategies
Dr. Xiaotao Jiang
Prof. Dr. Liping Ma
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Antimicrobial resistance
- Mobile genetic elements (MGEs)
- Phage therapy
- One health issue
- Environmental dissemination of ARGs
